Literature DB >> 7557027

Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene.

R Todd1, J McBride, T Tsuji, R B Donoff, M Nagai, M Y Chou, T Chiang, D T Wong.   

Abstract

We have identified, isolated, and partially characterized doc-1, a novel cDNA sequence whose activity is consistent with a suppressor of hamster oral carcinogenesis. Doc-1 is an evolutionarily conserved gene exhibiting loss of heterozygosity and marked reduction in expression in malignant hamster oral keratinocytes. The full-length doc-1 cDNA encodes an 87 amino acid product that shows a significant homology to one of the seven novel genes induced in mouse fibroblasts by TNF-alpha. Transfection of the full-length doc-1 cDNA into malignant hamster oral keratinocytes alters the behavior of the recipients in terms of morphology, growth rate, and anchorage-independent growth, suggesting reversion of transformation phenotypes. We propose that doc-1 is a novel tumor suppressor gene in oral cancer development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7557027     DOI: 10.1096/fasebj.9.13.7557027

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  24 in total

1.  Interactions of protein kinase CK2beta subunit within the holoenzyme and with other proteins.

Authors:  M Kusk; R Ahmed; B Thomsen; C Bendixen; O G Issinger; B Boldyreff
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein.

Authors:  S Shintani; H Ohyama; X Zhang; J McBride; K Matsuo; T Tsuji; M G Hu; G Hu; Y Kohno; M Lerman; R Todd; D T Wong
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Cdk2ap1 is required for epigenetic silencing of Oct4 during murine embryonic stem cell differentiation.

Authors:  Amit M Deshpande; Yan-Shan Dai; Yong Kim; Jeffrey Kim; Lauren Kimlin; Kai Gao; David T Wong
Journal:  J Biol Chem       Date:  2008-12-31       Impact factor: 5.157

4.  Progesterone is primary regulator of Cdk2ap1 gene expression and tissue-specific expression in the uterus.

Authors:  Y P Cheon; C H Kim
Journal:  J Endocrinol Invest       Date:  2010-03-30       Impact factor: 4.256

Review 5.  Molecular mechanisms of head and neck cancer.

Authors:  Amit M Deshpande; David T Wong
Journal:  Expert Rev Anticancer Ther       Date:  2008-05       Impact factor: 4.512

6.  Human cyclin-dependent kinase 2-associated protein 1 (CDK2AP1) is dimeric in its disulfide-reduced state, with natively disordered N-terminal region.

Authors:  Asli Ertekin; James M Aramini; Paolo Rossi; Paul G Leonard; Haleema Janjua; Rong Xiao; Melissa Maglaqui; Hsiau-Wei Lee; James H Prestegard; Gaetano T Montelione
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

7.  Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth.

Authors:  Takanori Tsuji; Soichiro Ibaragi; Kaori Shima; Miaofen G Hu; Miki Katsurano; Akira Sasaki; Guo-fu Hu
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

8.  Expression of cell cycle regulator cdk2ap1 suppresses tumor cell phenotype by non-cell-autonomous mechanisms.

Authors:  Olga Zolochevska; Marxa L Figueiredo
Journal:  Oral Oncol       Date:  2009-06-09       Impact factor: 5.337

9.  A novel regulatory factor recruits the nucleosome remodeling complex to wingless integrated (Wnt) signaling gene promoters in mouse embryonic stem cells.

Authors:  Jeffrey J Kim; Omar Khalid; Sheynie Vo; Ho-hyun Sun; David T W Wong; Yong Kim
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

10.  Targeted inactivation of p12, CDK2 associating protein 1, leads to early embryonic lethality.

Authors:  Yong Kim; Jim McBride; Lauren Kimlin; Eung-Kwon Pae; Amit Deshpande; David T Wong
Journal:  PLoS One       Date:  2009-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.